Cancer Research Meeting Calendar  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 3812-3817, September 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hangan, D.
Right arrow Articles by Chan, B. M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hangan, D.
Right arrow Articles by Chan, B. M. C.

An Epitope on VLA-6 ({alpha}6ß1) Integrin Involved in Migration but not Adhesion Is Required for Extravasation of Murine Melanoma B16F1 Cells in Liver1

Dolores Hangan, Vincent L. Morris, Linda Boeters, Christoph von Ballestrem, Shashi Uniyal and Bosco M. C. Chan2

Departments of Microbiology and Immunology [D. H., V. L. M., L. B., C. v. B., S. U., B. M. C. C.], Medical Biophysics [V. L. M.], and Oncology [V. L. M.], and Transplantation and Immunobiology Group [D. H., L. B., C. v. B., S. U., B. M. C. C.], John P. Robarts Research Institute, University of Western Ontario, London, Ontario, N6A 5K8 Canada

VLA-6 ({alpha}6ß1) integrin represents the major receptor for interaction with laminin substrate. It has been proposed that VLA-6 mediates tumor cell adhesion to the endothelium during extravasation. We have further explored this possibility using mouse melanoma B16F1 cells, which express VLA-6 as the principal laminin receptor, and two VLA-6 monoclonal antibodies (mAbs), MA6 and GoH3. Adhesion is a prerequisite of cell movement on matrix proteins. Thus, GoH3, which inhibited VLA-6-mediated adhesion, blocked cell movement on laminin. The recently prepared {alpha}6 integrin-specific mAb MA6 bound to an epitope in close proximity to GoH3, but it had no effect on VLA-6-mediated cell adhesion. We report here that although MA6 did not affect adhesion, it blocked mouse melanoma B16F1 cell movement on laminin to the same extent as GoH3. Results therefore demonstrate an active role of VLA-6 in providing cell movement as well as the initial adhesive event on laminin. In addition, mAb MA6 had no effect on the induction of tyrosine phosphorylation of focal adhesion kinase upon adhesion of B16F1 cells to laminin. Therefore, inhibition of cell movement by MA6 involved mechanism(s) other than an interference of VLA-6 signaling events leading to phosphorylation of focal adhesion kinase. The epitopes of GoH3 and MA6 may represent spatially and temporally related sites on VLA-6 that are involved during cell movement, or, alternatively, MA6 may inhibit the interaction of VLA-6 with associated cell surface molecules required for cell movement. In vivo videomicroscopy experiments also revealed that an inhibition of VLA-6 migratory function by MA6 resulted in a reduction in the ability of B16F1 to extravasate during hematogenous metastasis in the liver.

1 Supported by the Medical Research Council of Canada (B. M. C. C.), the Natural Sciences and Engineering Research Council of Canada (B. M. C. C.), and the Cancer Research Society and Academic Development Fund of the University of Western Ontario (V. L. M. and B. M. C. C.).

2 To whom requests for reprints should be addressed, at Transplantation and Immunobiology Group. John P. Robarts Research Institute, University of Western Ontario, 100 Perth Drive, London, Ontario, Canada N6A 5K8. Phone: (519) 663-3300, extension 4206; Fax: (519) 663-3789; E-mail: bosco@immune.rri.uwo.ca.

Received 1/27/97. Accepted 7/ 1/97.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
E. Delamarre, S. Taboubi, S. Mathieu, C. Berenguer, V. Rigot, J.-C. Lissitzky, D. Figarella-Branger, L. Ouafik, and J. Luis
Expression of Integrin {alpha}6{beta}1 Enhances Tumorigenesis in Glioma Cells
Am. J. Pathol., August 1, 2009; 175(2): 844 - 855.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. O. Ports, R. B. Nagle, G. D. Pond, and A. E. Cress
Extracellular Engagement of {alpha}6 Integrin Inhibited Urokinase-Type Plasminogen Activator-Mediated Cleavage and Delayed Human Prostate Bone Metastasis
Cancer Res., June 15, 2009; 69(12): 5007 - 5014.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Silletti, M. Yebra, B. Perez, V. Cirulli, M. McMahon, and A. M. P. Montgomery
Extracellular Signal-regulated Kinase (ERK)-dependent Gene Expression Contributes to L1 Cell Adhesion Molecule-dependent Motility and Invasion
J. Biol. Chem., July 9, 2004; 279(28): 28880 - 28888.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Q. D. Wu, J. H. Wang, C. Condron, D. Bouchier-Hayes, and H. P. Redmond
Human neutrophils facilitate tumor cell transendothelial migration
Am J Physiol Cell Physiol, April 1, 2001; 280(4): C814 - C822.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
C. Ballestrem, B. Wehrle-Haller, B. Hinz, and B. A. Imhof
Actin-dependent Lamellipodia Formation and Microtubule-dependent Tail Retraction Control-directed Cell Migration
Mol. Biol. Cell, September 1, 2000; 11(9): 2999 - 3012.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
D Nath, P. Slocombe, A Webster, P. Stephens, A. Docherty, and G Murphy
Meltrin gamma(ADAM-9) mediates cellular adhesion through alpha(6)beta(1 )integrin, leading to a marked induction of fibroblast cell motility
J. Cell Sci., January 6, 2000; 113(12): 2319 - 2328.
[Abstract] [PDF]


Home page
Cell Growth Differ.Home page
B. L. Ziober, Y. Q. Chen, D. M. Ramos, N. Waleh, and R. H. Kramer
Expression of the {{alpha}}7{beta}1 Laminin Receptor Suppresses Melanoma Growth and Metastatic Potential
Cell Growth Differ., July 1, 1999; 10(7): 479 - 490.
[Abstract] [Full Text]


Home page
Mol. Biol. CellHome page
A. Lochter, M. Navre, Z. Werb, and M. J. Bissell
alpha 1 and alpha 2 Integrins Mediate Invasive Activity of Mouse Mammary Carcinoma Cells through Regulation of Stromelysin-1 Expression
Mol. Biol. Cell, February 1, 1999; 10(2): 271 - 282.
[Abstract] [Full Text]


Home page
Mol. Biol. CellHome page
R. L. Yauch, F. Berditchevski, M. B. Harler, J. Reichner, and M. E. Hemler
Highly Stoichiometric, Stable, and Specific Association of Integrin alpha 3beta 1 with CD151 Provides a Major Link to Phosphatidylinositol 4-Kinase, and May Regulate Cell Migration
Mol. Biol. Cell, October 1, 1998; 9(10): 2751 - 2765.
[Abstract] [Full Text]


Home page
Mol. Biol. CellHome page
S. Z. Domanico, A. J. Pelletier, W. L. Havran, and V. Quaranta
Integrin alpha 6Abeta 1 Induces CD81-dependent Cell Motility without Engaging the Extracellular Matrix Migration Substrate
Mol. Biol. Cell, November 1, 1997; 8(11): 2253 - 2265.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Sixt, R. Hallmann, O. Wendler, K. Scharffetter-Kochanek, and L. M. Sorokin
Cell Adhesion and Migration Properties of beta 2-Integrin Negative Polymorphonuclear Granulocytes on Defined Extracellular Matrix Molecules. RELEVANCE FOR LEUKOCYTE EXTRAVASATION
J. Biol. Chem., May 25, 2001; 276(22): 18878 - 18887.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.